drugset / Trial / NCT00330798

A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief

NCT00330798

Phase 4 Completed 40 enrolled Alcon Research Matthew Caldwell · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery.

Timeline

Start
2006-02
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nepafenac Other / unclassified 0.1 % Topical

Indications

No indication recorded.